Dark

BTX
BlackRock Technology and Private Equity Term Trust
stock NYSE

At Close

Jul 1, 2025 3:59:55 PM EDT

7.32USD-0.678%(-0.05)1,486,503

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 1, 2025 9:12:30 AM EDT

7.35USD-0.271%(-0.02)5,200

After-hours

Jul 1, 2025 4:00:30 PM EDT

7.32USD-0.001%(0.00)415

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

1.56B

Headquarters

CA, USA

Industry

Biotechnology

Last Dividend

Mar 14, 20250.086

Last Split

Oct 17, 20221for20reverse

GERN MNTA PDLI OMER BAX SNY TEVA TECH GENE XLV

BTX Stats

Avg. Vol. 10 Day

870,205

Avg. Vol. 30 Day

667,943

Employees

Market Cap

1,561,635,243

Shares Out.

213,338,148

On/Off Exchange

43%/57%

6 Month Beta

1.12

2 Year Beta

0.99

3 Year Beta

0.96

52 Week Low

5.10

52 Week High

8.12

SMA50

6.77

SMA200

8.47

1 Week

+1.11%

1 Month

+4.72%

3 Month

+16.38%

6 Month

-6.87%

2 Year

+78.45%

5 Year

-91.61%

Profile

Brooklyn is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. The company is also exploring opportunities to advance therapies using leading edge gene editing/cell therapy technology through its option agreements with Factor Bioscience and Novellus. Brooklyn's most advanced program is studying the safety and efficacy of IRX-2 in patients with head and neck cancer. In a Phase 2A clinical trial in head and neck cancer, IRX-2 demonstrated an overall survival benefit. Additional studies are either underway or planned in other solid tumor cancer indications.

BTX Stock Summary

BlackRock Technology and Private Equity Term Trust (NYSE:BTX) stock price today is $7.32, and today's volume is 1,486,503. BTX is down -0.678% today. The 30 day average volume is 667,943. BTX market cap is 1.56B with 213,338,148 shares outstanding.